Forecasted impacts of a sofosbuvir-based national hepatitis C treatment programme on Egypt’s hepatocellular cancer epidemic: simulation of alternatives

BACKGROUND: Egypt is experiencing a hepatocellular cancer (HCC) epidemic due to widespread hepatitis C virus (HCV) transmission. The use of sofosbuvir-related therapies producing improved treatment success has permitted an updated, nationwide, HCV treatment programme with expanded coverage. This stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Wenkang, Soliman, Amr S, Anwar, Wagida A, Hablas, Ahmed, El Din, Tamer B, Ramadan, Mohamed, Seifeldin, Ibrahim A, Wilson, Mark L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914708/
https://www.ncbi.nlm.nih.gov/pubmed/29707244
http://dx.doi.org/10.1136/bmjgh-2017-000572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914708/
https://www.ncbi.nlm.nih.gov/pubmed/29707244
http://dx.doi.org/10.1136/bmjgh-2017-000572

Ejemplares similares